Heterocyclic selective androgen receptor modulators and methods of use thereof

Details for Australian Patent Application No. 2009202683 (hide)

Owner University of Tennessee Research Foundation

Inventors Dalton, James T.; Miller, Duane D.

Agent Griffith Hack

Pub. Number AU-A-2009202683

Parent 2003287076

Filing date 2 July 2009

Wipo publication date 23 July 2009

International Classifications

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/84 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

Event Publications

16 July 2009 Complete Application Filed

23 July 2009 Application Open to Public Inspection

  Published as AU-A-2009202683

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202684-Abuse resistance opioid transdermal delivery device

2009202682-Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof